| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2008PNAS..105.4301O |
| P356 | DOI | 10.1073/PNAS.0800459105 |
| P932 | PMC publication ID | 2393789 |
| P698 | PubMed publication ID | 18332422 |
| P5875 | ResearchGate publication ID | 5520666 |
| P50 | author | Geert-Jan van Gemert | Q45380524 |
| Marga van de Vegte-Bolmer | Q45380602 | ||
| Adrian Luty | Q55176085 | ||
| Robert W Sauerwein | Q60043950 | ||
| Will Roeffen | Q72536015 | ||
| Hendrik Gerard Stunnenberg | Q85416865 | ||
| P2093 | author name string | Anita Kaan | |
| Nikolay S Outchkourov | |||
| Danielle Schuiffel | |||
| Josephine Jansen | |||
| P2860 | cites work | Pathways for protein disulphide bond formation | Q28141294 |
| A central role for P48/45 in malaria parasite male gamete fertility | Q30043154 | ||
| Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. | Q30982324 | ||
| Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum | Q30984883 | ||
| Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia | Q33235842 | ||
| Malaria transmission-blocking vaccines--how can their development be supported? | Q33853275 | ||
| Current developments in malaria transmission-blocking vaccines | Q34451883 | ||
| Transmission-blocking vaccines. | Q34680152 | ||
| Recombinant protein folding and misfolding in Escherichia coli | Q35940945 | ||
| Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito | Q36351262 | ||
| Malaria vaccines: are we getting closer? | Q36748243 | ||
| Malaria transmission-blocking vaccines: the bonus of effective malaria control | Q36785468 | ||
| Measurement by membrane feeding of reduction in Plasmodium falciparum transmission induced by endemic sera | Q40959724 | ||
| A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults | Q43945792 | ||
| Plasmodium falciparum transmission blocking monoclonal antibodies recognize monovalently expressed epitopes | Q44146493 | ||
| Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures | Q44166470 | ||
| Sexual-stage antibody responses to P. falciparum in endemic populations | Q44167654 | ||
| A comparison of transmission-blocking activity with reactivity in a Plasmodium falciparum 48/45-kD molecule-specific competition enzyme-linked immunosorbent assay. | Q44169960 | ||
| Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies. | Q47829675 | ||
| Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum | Q48103837 | ||
| A system for concomitant overexpression of four periplasmic folding catalysts to improve secretory protein production in Escherichia coli. | Q54464752 | ||
| Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen | Q73509627 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| protein folding | Q847556 | ||
| malaria transmission | Q56928847 | ||
| P304 | page(s) | 4301-4305 | |
| P577 | publication date | 2008-03-10 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice | |
| P478 | volume | 105 |
| Q92669430 | A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system |
| Q91723010 | A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria |
| Q39467691 | A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies |
| Q36511421 | A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants |
| Q34991300 | A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins |
| Q39520295 | A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages |
| Q33485233 | A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli |
| Q33818046 | A research agenda for malaria eradication: vaccines |
| Q33670142 | A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies |
| Q90732916 | An MFS-Domain Protein Pb115 Plays a Critical Role in Gamete Fertilization of the Malaria Parasite Plasmodium berghei |
| Q38891629 | Antibodies elicited during natural infection in a predominantly Plasmodium falciparum transmission area cross-react with sexual stage-specific antigen in P. vivax |
| Q37546481 | Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria |
| Q40110842 | Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana |
| Q37274832 | Approaches to malaria vaccine development using the retrospectroscope |
| Q56358374 | Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential |
| Q37351351 | Comparative Genomics and Systems Biology of Malaria Parasites Plasmodium |
| Q42682357 | Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens |
| Q35718341 | Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum |
| Q44169836 | Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques |
| Q36889732 | Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45. |
| Q96813794 | Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230 |
| Q37742202 | Current status of vaccination against African trypanosomiasis. |
| Q39331193 | Dynamics of the Human Infectious Reservoir for Malaria Determined by Mosquito Feeding Assays and Ultrasensitive Malaria Diagnosis in Burkina Faso |
| Q34177472 | Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination |
| Q89864479 | Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate |
| Q36144661 | Expression of 6-Cys Gene Superfamily Defines Babesia bovis Sexual Stage Development within Rhipicephalus microplus. |
| Q40159945 | Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite |
| Q58765365 | Functional Conservation of P48/45 Proteins in the Transmission Stages of (Human Malaria Parasite) and . (Murine Malaria Parasite) |
| Q28365035 | Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate |
| Q36941152 | Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons |
| Q56348083 | Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli |
| Q36336302 | Genetic diversity of transmission-blocking vaccine candidate Pvs48/45 in Plasmodium vivax populations in China |
| Q30386746 | Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45. |
| Q43645737 | Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii |
| Q36393216 | Identification of candidate transmission-blocking antigen genes in Theileria annulata and related vector-borne apicomplexan parasites |
| Q92001627 | Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites |
| Q90706801 | Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)2 of Plasmodium falciparum in a Mouse Model |
| Q38962773 | Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation |
| Q36082968 | Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses |
| Q42174586 | In vivo deglycosylation of recombinant proteins in plants by co-expression with bacterial PNGase F. |
| Q41475379 | In vivo production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expression with Endo-β-N-acetylglucosaminidase H (Endo H) of Streptomyces plicatus. |
| Q48021662 | Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission |
| Q35712522 | Malaria eradication and elimination: views on how to translate a vision into reality |
| Q36795388 | Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America. |
| Q37573746 | Malaria vaccine research: lessons from 2008/9. |
| Q37018637 | Malaria vaccines and their potential role in the elimination of malaria |
| Q85417673 | Male-Specific Protein Disulphide Isomerase Function is Essential for Plasmodium Transmission and a Vulnerable Target for Intervention. |
| Q54217209 | Modeling the impact of Plasmodium falciparum sexual stage immunity on the composition and dynamics of the human infectious reservoir for malaria in natural settings. |
| Q36079818 | Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles |
| Q38689928 | Naturally acquired immunity to sexual stage P. falciparum parasites. |
| Q35216634 | New antigens for a multicomponent blood-stage malaria vaccine |
| Q37549510 | Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro |
| Q36236790 | Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles |
| Q37713285 | Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding |
| Q39343656 | Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe |
| Q39146031 | Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners. |
| Q48007592 | Production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expressing bacterial PNGase F. |
| Q34034756 | Production of unique immunotoxin cancer therapeutics in algal chloroplasts |
| Q47251697 | Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity |
| Q34618434 | Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays |
| Q36394182 | Recent advances in recombinant protein-based malaria vaccines |
| Q38818196 | Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon |
| Q35182086 | Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes |
| Q39246146 | Reduced immunogenicity of Plasmodium falciparum gamete surface antigen (Pfs48/45) in mice after disruption of disulphide bonds - evaluating effect of interferon-γ-inducible lysosomal thiol reductase. |
| Q30432107 | Sequence polymorphisms in Pvs48/45 and Pvs47 gametocyte and gamete surface proteins in Plasmodium vivax isolated in Korea |
| Q33847933 | Sex and death: the effects of innate immune factors on the sexual reproduction of malaria parasites |
| Q36998403 | Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response. |
| Q28072195 | Strategies & recent development of transmission-blocking vaccines against Plasmodium falciparum |
| Q30390705 | Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230. |
| Q27230051 | Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41 |
| Q57154118 | Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody |
| Q58115505 | Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45 |
| Q27678432 | Structure of the Plasmodium 6-cysteine s48/45 domain |
| Q36344935 | Targeting molecular interactions essential for Plasmodium sexual reproduction |
| Q46246718 | Targeting the Conserved Fusion Loop of HAP2 Inhibits the Transmission of Plasmodium berghei and falciparum |
| Q90137873 | The C-terminal region of the Plasmodium yoelii microgamete surface antigen PyMiGS induces potent anti-malarial transmission-blocking immunity in mice |
| Q30039034 | The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro |
| Q57296267 | The Plasmodium falciparum male gametocyte protein P230p, a paralog of P230, is vital for ookinete formation and mosquito transmission |
| Q59923959 | The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes |
| Q28744581 | The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania |
| Q38789240 | The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle |
| Q33553363 | Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility |
| Q31153899 | Towards a comprehensive Plasmodium falciparum merozoite cell surface and secreted recombinant protein library |
| Q38775588 | Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine |
| Q40979878 | Transmission blocking malaria vaccines: Assays and candidates in clinical development |
| Q37704246 | Transmission blocking vaccines to control insect-borne diseases: a review |
| Q92954169 | Transmission-Blocking Vaccines: Old Friends and New Prospects |
| Q36267184 | Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants |
| Q36906724 | Transmission-blocking interventions eliminate malaria from laboratory populations. |
| Q49732059 | Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity |
Search more.